MedX Health Corp.’s SIAscopy Technology Being Introduced to the Spanish Market
May 14 2018 - 7:35AM
Business Wire
MedX Health Corp. (“MedX”) (TSX-V: MDX) announced that it has
shipped an initial order in excess of $120,000 of its SIAscopy
technology to Spain through its marketing partnership with OncoTech
LLC.
“Completing this large order early in the second quarter
reinforces the growing interest in our technology as a pain-free
non-invasive skin assessment tool,” noted Rob von der Porten,
MedX's CEO. “OncoTech sees this as a first step in gaining
awareness followed by further market penetration in Spain,
including the application of MedX’s telemedicine platform in this
large market. In addition to these initiatives in Spain, OncoTech
is working to duplicate this approach in other Spanish speaking
countries around the world, and we are working with them to
complete the regulatory approvals in new markets.”
Mr. von der Porten noted that “skin cancers in Hispanics have
risen more than 20% in the past two decades, and our technology can
assist in the earlier detection of melanoma and other skin cancers,
thereby saving lives and reducing the financial burden on
healthcare systems.”
About MedX
MedX, headquartered in Mississauga, Ontario, is a leading
medical device company focused on skin cancer with its SIAscopy
technology that is imbedded in its products SIAMETRICS™, SIMSYS™,
and MoleMate™, which MedX manufactures in its ISO 13485 certified
facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held
devices that use patented technology utilizing light and its
remittance to view up to 2 mm beneath suspicious moles and lesions
in a pain free, non-invasive manner, with its software then
creating real-time images for physicians and dermatologists to
evaluate all types of moles or lesions within seconds. These
products are Health Canada, FDA (US), ARTG and CE cleared for use
in Canada, the US, Australia, New Zealand, the European Union and
Turkey. MedX also designs, manufactures and distributes quality
laser and light therapy technologies to provide drug free and
non-invasive treatment of tissue damage and pain.
www.medxhealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180514005659/en/
MedX Health CorpRob von der Porten, CEO905-670-4428 ext
226orMedia RelationsDeborah
Thompsondthompson@medxhealth.com416-918-9551
Medx Health (TSXV:MDX)
Historical Stock Chart
From Apr 2024 to May 2024
Medx Health (TSXV:MDX)
Historical Stock Chart
From May 2023 to May 2024